Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Galera Therapeutics Inc (NQ: GRTX )

2.140 +0.080 (+3.88%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 133,432
Open 2.050
Bid (Size) 2.180 (19)
Ask (Size) 2.350 (8)
Prev. Close 2.060
Today's Range 2.050 - 2.182
52wk Range 1.120 - 2.840
Shares Outstanding 28,500,066
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
NDA based on two positive randomized, double-blinded, placebo-controlled trials which enrolled a total of 678 patients 
From Galera Therapeutics
Via Globe NewsWire

Performance

YTD
+44.59%
+44.59%
1 Month
+43.62%
+43.62%
3 Month
+47.59%
+47.59%
6 Month
+84.48%
+84.48%
1 Year
-21.90%
-21.90%

More News

Read More
Galera to Present at Piper Sandler Annual Healthcare Conference
From Galera Therapeutics
Via Globe NewsWire
Recap: Galera Therapeutics Q2 Earnings
Via Benzinga
Galera Therapeutics' Rucosopasem Shows Early Anti-Cancer Activity, Pulmonary Function Preservation
Via Benzinga
Galera Therapeutics: Q1 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
From Galera Therapeutics
Via Globe NewsWire
Galera Therapeutics' Avasopasem Reduces Chemo-Related Kidney Disease By 50% Versus Placebo At One-Year
Via Benzinga
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
From Galera Therapeutics
Via Globe NewsWire
Galera Posts Topline Data From Avasopasem Study In Chemoradiotherapy-Induced Esophagitis
Via Benzinga
Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
Via Benzinga
Galera Therapeutics: Q4 Earnings Insights
Via Benzinga
110 Biggest Movers From Friday
Via Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
65 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.